BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8132958)

  • 1. [Evaluation of second look laparotomy in the management of epithelial ovarian tumors. 88 interventions performed at the Dijon CAC between 1979 and 1990].
    Ollivier L; Fraisse J; Barillot I; Mayer F; Maingon P; Cuisenier J
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(8):838-42. PubMed ID: 8132958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
    Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
    Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-look laparotomy in epithelial ovarian cancer.
    Copeland LJ; Vaccarello L; Lewandowski GS
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):155-66. PubMed ID: 8015761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A re-evaluation laparotomy in ovarian neoplasms].
    Mayerson D; Mondion M; Wild R; Barrena N; Badía J; Oyarzún E
    Rev Chil Obstet Ginecol; 1993; 58(6):438-43. PubMed ID: 7991867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A formula for predicting the risk of a positive second-look laparotomy in epithelial ovarian cancer: implications for a randomized trial.
    Morgan MA; Noumoff JS; King S; Mikuta JJ
    Obstet Gynecol; 1992 Dec; 80(6):944-8. PubMed ID: 1333064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Technique and preliminary results in second-look laparoscopy in epithelial malignant ovarian tumors].
    Canis M; Chapron C; Mage G; Pouly JL; Wattiez A; Bassil S; Raymond F; Bruhat MA
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(6):655-63. PubMed ID: 1430912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients.
    Obermair A; Sevelda P
    Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the role of second-look surgery in ovarian cancer.
    Chambers SK; Chambers JT; Kohorn EI; Lawrence R; Schwartz PE
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):404-8. PubMed ID: 3405557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
    Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
    Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Times and sites of relapses after negative second look in advanced epithelial ovarian cancer.
    Maggino T; Gadducci A; Romagnolo C; Fanucchi A; Fioretti P
    Eur J Surg Oncol; 1994 Apr; 20(2):146-50. PubMed ID: 8181580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors].
    Ferrero JM; Largillier R; Ramaioli A; Heudier P; Teissier E; Namer M
    Bull Cancer; 1997 Jul; 84(7):722-8. PubMed ID: 9339198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer.
    Bozkurt N; Yuce K; Basaran M; Kose F; Ayhan A
    Obstet Gynecol; 2004 Jan; 103(1):82-5. PubMed ID: 14704249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of women with advanced ovarian cancer and complete pathologic response at second-look laparotomy.
    Bolis G; Villa A; Guarnerio P; Ferraris C; Gavoni N; Giardina G; Melpignano M; Scarfone G; Zanaboni F; Parazzini F
    Cancer; 1996 Jan; 77(1):128-31. PubMed ID: 8630918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytoreductive surgery in the management of stage IV epithelial ovarian cancer].
    Zang R; Zhang Z; Chen J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):197-9. PubMed ID: 11776157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
    Peccatori F; Bonazzi C; Chiari S; Landoni F; Colombo N; Mangioni C
    Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary cytoreductive surgery at second-look laparotomy in advanced ovarian cancer: a Gynecologic Oncology Group Study.
    Williams L; Brunetto VL; Yordan E; DiSaia PJ; Creasman WT
    Gynecol Oncol; 1997 Aug; 66(2):171-8. PubMed ID: 9264559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of lymphadenectomy and survival in stage I ovarian cancer patients.
    Chan JK; Munro EG; Cheung MK; Husain A; Teng NN; Berek JS; Osann K
    Obstet Gynecol; 2007 Jan; 109(1):12-9. PubMed ID: 17197582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
    Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
    Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second look for ovarian cancer: laparoscopy or Laparotomy? A prospective comparative study.
    Clough KB; Ladonne JM; Nos C; Renolleau C; Validire P; Durand JC
    Gynecol Oncol; 1999 Mar; 72(3):411-7. PubMed ID: 10053115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.